4University Group Diabetes Program. A study of thd offects of hypoglycemic agents on vascular complications in patients with adult- onset diabetes Diabetes 1970 ; 19 [ Suppl2 ] :747 - 830. 被引量：1
5Noma A. ATP-regulated , K ^+ channesis in cardiac muscle. Nature 1983 ;305:147 - 148. 被引量：1
6Cleveland JC Jr, Heldrum DR, Cain BG, et al. Oral sulfony- lurea hypoglycemic agents prevent ischemic preconditioning in human myoeocrdium two paradoxes revisited. Circulation 1997 ;96:29 - 32. 被引量：1
7Nissen SE, Wolski K. Effect of rosiglitazone on the risx of myocardial infarction and death from cardiorascular causes. N Engl J Med 2007 ;356:2457 -2471. 被引量：1
8Watkins PB, Whitcomb RW. Hepatic dysfunction associated with troglitazone. N Engl J Med 1998;338:916 -917. 被引量：1
9Lebovitz HF, Kreider M, Freed MI. Evaluation of liver func- tion in type2 diabetic patients during clinical trials evidence that rosigli- tazone does not cause bepatic dysfunction. Diabetes Care 2002 ; 25 : 815 -823. 被引量：1
10Lebovitz HE. Oral therapies for diabetic hyperglycemta Endo- crinal Metab Clin North Am 2001 ;30:909 -933. 被引量：1
